199 related articles for article (PubMed ID: 16343526)
21. Therapeutic dendritic-cell vaccine for simian AIDS.
Lu W; Wu X; Lu Y; Guo W; Andrieu JM
Nat Med; 2003 Jan; 9(1):27-32. PubMed ID: 12496959
[TBL] [Abstract][Full Text] [Related]
22. Protection of macaques against vaginal SHIV challenge by systemic or mucosal and systemic vaccinations with HIV-envelope.
Barnett SW; Srivastava IK; Kan E; Zhou F; Goodsell A; Cristillo AD; Ferrai MG; Weiss DE; Letvin NL; Montefiori D; Pal R; Vajdy M
AIDS; 2008 Jan; 22(3):339-48. PubMed ID: 18195560
[TBL] [Abstract][Full Text] [Related]
23. Alterations in antibody-dependent cellular cytotoxicity during the course of HIV-1 infection. Humoral and cellular defects.
Tyler DS; Stanley SD; Nastala CA; Austin AA; Bartlett JA; Stine KC; Lyerly HK; Bolognesi DP; Weinhold KJ
J Immunol; 1990 May; 144(9):3375-84. PubMed ID: 2329275
[TBL] [Abstract][Full Text] [Related]
24. Antibody-dependent cell-mediated cytotoxicity: a flow cytometry-based assay using fluorophores.
Wilkinson RW; Lee-MacAry AE; Davies D; Snary D; Ross EL
J Immunol Methods; 2001 Dec; 258(1-2):183-91. PubMed ID: 11684135
[TBL] [Abstract][Full Text] [Related]
25. Thaw-and-use target cells pre-labeled with calcein AM for antibody-dependent cell-mediated cytotoxicity assays.
Chung S; Nguyen V; Lin YL; Kamen L; Song A
J Immunol Methods; 2017 Aug; 447():37-46. PubMed ID: 28434980
[TBL] [Abstract][Full Text] [Related]
26. Higher Baseline ADCC Responses in Chronic Nonprogressive HIV Infection Are Associated with Reduced HIV Burden in Later Course of Disease.
Talathi S; Bagul R; Ghate M; Kulkarni S; Thakar M
Viral Immunol; 2020 Mar; 33(2):77-85. PubMed ID: 31976826
[TBL] [Abstract][Full Text] [Related]
27. The utility of ADCC responses in HIV infection.
Chung A; Rollman E; Johansson S; Kent SJ; Stratov I
Curr HIV Res; 2008 Nov; 6(6):515-9. PubMed ID: 18991616
[TBL] [Abstract][Full Text] [Related]
28. Development of a novel flow cytometric cell-mediated cytotoxicity assay using the fluorophores PKH-26 and TO-PRO-3 iodide.
Lee-MacAry AE; Ross EL; Davies D; Laylor R; Honeychurch J; Glennie MJ; Snary D; Wilkinson RW
J Immunol Methods; 2001 Jun; 252(1-2):83-92. PubMed ID: 11334968
[TBL] [Abstract][Full Text] [Related]
29. In vitro reduction of virus infectivity by antibody-dependent cell-mediated immunity.
Forthal DN; Landucci G
J Immunol Methods; 1998 Nov; 220(1-2):129-38. PubMed ID: 9839934
[TBL] [Abstract][Full Text] [Related]
30. Three-colour flow cytometric method to measure antibody-dependent tumour cell killing by cytotoxicity and phagocytosis.
Bracher M; Gould HJ; Sutton BJ; Dombrowicz D; Karagiannis SN
J Immunol Methods; 2007 Jun; 323(2):160-71. PubMed ID: 17531261
[TBL] [Abstract][Full Text] [Related]
31. An improved assay for antibody dependent cellular cytotoxicity based on time resolved fluorometry.
Patel AK; Boyd PN
J Immunol Methods; 1995 Jul; 184(1):29-38. PubMed ID: 7622867
[TBL] [Abstract][Full Text] [Related]
32. A high-performance, non-radioactive potency assay for measuring cytotoxicity: A full substitute of the chromium-release assay targeting the regulatory-compliance objective.
Rossignol A; Bonnaudet V; Clémenceau B; Vié H; Bretaudeau L
MAbs; 2017 Apr; 9(3):521-535. PubMed ID: 28281922
[TBL] [Abstract][Full Text] [Related]
33. Detection of antibody-dependent cell-mediated cytotoxicity by automated flow cytometry. Comparison to a chromium release assay and characterization of the effector cell subpopulation.
Attallah AM; Folks T; Noguchi PD; Noguchi T
J Immunol Methods; 1980; 36(3-4):325-33. PubMed ID: 7000911
[TBL] [Abstract][Full Text] [Related]
34. An improved europium release assay for complement-mediated cytolysis.
Cui J; Bystryn JC
J Immunol Methods; 1992 Feb; 147(1):13-9. PubMed ID: 1541836
[TBL] [Abstract][Full Text] [Related]
35. Detection of human ADCC activity using automated flow cytometry.
Attallah AM; Naguchi PD; Folks T; Noguchi CT
Experientia; 1980 Jan; 36(1):124-5. PubMed ID: 6987071
[TBL] [Abstract][Full Text] [Related]
36. High-Throughput GLP-Capable Target Cell Visualization Assay for Measuring Cell-Mediated Cytotoxicity.
Welter A; Sundararaman S; Li R; Zhang T; Karulin AY; Lehmann A; Naeem V; Roen DR; Kuerten S; Lehmann PV
Cells; 2018 Apr; 7(5):. PubMed ID: 29695103
[TBL] [Abstract][Full Text] [Related]
37. A simplified isotope release assay for cell-mediated cytotoxicity against anchorage dependent target cells.
Timonen T; Saksela E
J Immunol Methods; 1977; 18(1-2):123-32. PubMed ID: 915305
[TBL] [Abstract][Full Text] [Related]
38. Notice of retraction of: "Enhancement of natural killer cell activation and antibody-dependent cellular cytotoxicity by interferon-alpha and interleukin-12 in vaginal mucosae SIV mac251-infected Macaca fascicularis," Viral Immunology, March 1,2002, 15(1): 197-212.
Woodland D
Viral Immunol; 2008 Sep; 21(3):277. PubMed ID: 18788936
[No Abstract] [Full Text] [Related]
39. A robust, high-throughput assay to determine the phagocytic activity of clinical antibody samples.
Ackerman ME; Moldt B; Wyatt RT; Dugast AS; McAndrew E; Tsoukas S; Jost S; Berger CT; Sciaranghella G; Liu Q; Irvine DJ; Burton DR; Alter G
J Immunol Methods; 2011 Mar; 366(1-2):8-19. PubMed ID: 21192942
[TBL] [Abstract][Full Text] [Related]
40. Non-neutralizing Antibodies Targeting the V1V2 Domain of HIV Exhibit Strong Antibody-Dependent Cell-mediated Cytotoxic Activity.
Mayr LM; Decoville T; Schmidt S; Laumond G; Klingler J; Ducloy C; Bahram S; Zolla-Pazner S; Moog C
Sci Rep; 2017 Oct; 7(1):12655. PubMed ID: 28978939
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
